| Product Code: ETC7539068 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India cancer therapeutics market import shipment demonstrated a steady expansion with a CAGR of 3.0% from 2020 to 2024. Notably, between 2023 and 2024, the growth rate surged by 26.5%, indicating a significant momentum towards the end of the period. Overall, the market exhibited positive growth trends and promising momentum.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cancer Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Cancer Therapeutics Market - Industry Life Cycle |
3.4 India Cancer Therapeutics Market - Porter's Five Forces |
3.5 India Cancer Therapeutics Market Revenues & Volume Share, By APPLICATION, 2021 & 2031F |
3.6 India Cancer Therapeutics Market Revenues & Volume Share, By TOP SELLING DRUGS, 2021 & 2031F |
4 India Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing awareness and early diagnosis initiatives |
4.2.3 Technological advancements in cancer therapeutics |
4.3 Market Restraints |
4.3.1 High cost of cancer treatments |
4.3.2 Limited access to advanced cancer therapies in rural areas |
4.3.3 Stringent regulatory requirements for drug approval |
5 India Cancer Therapeutics Market Trends |
6 India Cancer Therapeutics Market, By Types |
6.1 India Cancer Therapeutics Market, By APPLICATION |
6.1.1 Overview and Analysis |
6.1.2 India Cancer Therapeutics Market Revenues & Volume, By APPLICATION, 2021- 2031F |
6.1.3 India Cancer Therapeutics Market Revenues & Volume, By Blood cancer, 2021- 2031F |
6.1.4 India Cancer Therapeutics Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.5 India Cancer Therapeutics Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.1.6 India Cancer Therapeutics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 India Cancer Therapeutics Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.1.8 India Cancer Therapeutics Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.1.9 India Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.1.10 India Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.2 India Cancer Therapeutics Market, By TOP SELLING DRUGS |
6.2.1 Overview and Analysis |
6.2.2 India Cancer Therapeutics Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.2.3 India Cancer Therapeutics Market Revenues & Volume, By Avastin, 2021- 2031F |
6.2.4 India Cancer Therapeutics Market Revenues & Volume, By Herceptin, 2021- 2031F |
6.2.5 India Cancer Therapeutics Market Revenues & Volume, By Rituxan, 2021- 2031F |
6.2.6 India Cancer Therapeutics Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.2.7 India Cancer Therapeutics Market Revenues & Volume, By Gleevec, 2021- 2031F |
6.2.8 India Cancer Therapeutics Market Revenues & Volume, By Imbruvica, 2021- 2031F |
6.2.9 India Cancer Therapeutics Market Revenues & Volume, By Imbruvica, 2021- 2031F |
7 India Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 India Cancer Therapeutics Market Export to Major Countries |
7.2 India Cancer Therapeutics Market Imports from Major Countries |
8 India Cancer Therapeutics Market Key Performance Indicators |
8.1 Number of cancer cases diagnosed annually |
8.2 Adoption rate of innovative cancer therapies |
8.3 Government funding allocated to cancer research and treatment |
8.4 Patient survival rates for different types of cancer |
8.5 Number of healthcare facilities offering cancer treatment services |
9 India Cancer Therapeutics Market - Opportunity Assessment |
9.1 India Cancer Therapeutics Market Opportunity Assessment, By APPLICATION, 2021 & 2031F |
9.2 India Cancer Therapeutics Market Opportunity Assessment, By TOP SELLING DRUGS, 2021 & 2031F |
10 India Cancer Therapeutics Market - Competitive Landscape |
10.1 India Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here